Search results for "Thromboprophylaxis"
July 13, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/07/13/
Longer venous thromboprophylaxis after total hip replacement decreases events, ups minor bleeding risk
Venous thromboprophylaxis for 21 days or more after total hip replacement lowers risk for venous thromboembolism, pulmonary embolism and deep venous thrombosis while increasing the risk for minor bleeding, according to a new study.
https://acphospitalist.acponline.org/weekly/archives/2012/03/21/3.htm
21 Mar 2012
March 16, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/03/16/
Very elderly patients can benefit from well-managed vitamin K antagonist thromboprophylaxis, study suggests
Adequate management of vitamin K antagonist (VKA) therapy in trained centers allowed very old and frail patients to benefit from VKA thromboprophylaxis, an Italian study concluded.
https://acphospitalist.acponline.org/weekly/archives/2011/08/10/3.htm
10 Aug 2011
December 2020
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2020/12/
Guidelines, studies make recommendations on VTE prophylaxis for inpatients with COVID-19
A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/2.htm
10 Jun 2020
Thromboprophylaxis, heart failure decongestion, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/12/recent-research.htm
15 Dec 2020
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020
DOACs better than heparin for periop thromboprophylaxis, review finds
The systematic review and network meta-analysis found lower rates of symptomatic venous thromboembolism in surgical patients given direct oral anticoagulants (DOACs) versus the standard dose of low-molecular-weight heparin, without a significant increase in bleeding.
https://acphospitalist.acponline.org/archives/2022/03/16/doacs-better-than-heparin-for-periop-thromboprophylaxis.htm
16 Mar 2022
February 23, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/02/23/